ArticleAnalytical and bioanalytical chemistry2025
GPBD: high-confidence N-glycopeptide identification via glycopeptide boundary discriminator.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate identification of both glycan and peptide components is critical for mass spectrometry-based glycoproteomics, yet high-confidence glycan spectrum matches (GSMs) are often discarded during quality control due to low-confidence peptide spectrum matches (PSMs). To address this, we developed the glycopeptide boundary discriminator (GPBD), a new methodology that integrates glycan and peptide information to precisely define the glycan-peptide boundary. The GPBD framework consists of three main steps, for each spectrum: (1) enumerating several possible peptide masses from the core Y-ion ladder (low-energy scan) and then uses b/y evidence in the high-energy scan to rank peptide candidates, (2) for each candidate, matching a series of glycan ions to build a glycan ion pattern (GIP), (3) a classifier discriminates GIPs of the top candidates to finalize peptide assignment. This method is integrated into StrucGP, our previously developed software for N-glycopeptide identification. Experiments using GPBD on mouse brain and sperm datasets demonstrated an increase in glycopeptide spectra matches (GPSMs) due to more accurate peptide identification, while simultaneously maintaining high confidence in glycan identification. Furthermore, analysis of fetuin datasets showed GPBD's potential usage in database-independent peptide identification pipeline.
Indexed as
Identifiers
41174245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.